title: [Clinical diagnosis of the olfactory nerve transport function].
abstract: Nasal administration of macromolecular drugs (peptides, nanoparticles) has a possibility to enable a drug delivery system beyond the blood brain barrier via olfactory nerve transport. Basic research on nasal drug delivery to the brain has been well studied. However, evaluation of the olfactory nerve transport function in patients with olfactory disorders has yet to be done, although such an evaluation is important in selecting candidates for clinical trials. Current olfactory function tests are useful for the analysis of olfactory thresholds in olfaction-impaired patients. However, the usefulness of using the increase in olfactory thresholds in patients as an index for evaluating olfactory nerve damage has not been confirmed because of the difficulty in directly evaluating the viability of the peripheral olfactory nerves. Nasally administered thallium-201 migrates to the olfactory bulb, as has been shown in healthy volunteers. Furthermore, transection of olfactory nerve fibers in mice significantly decreases migration of nasally administered thallium-201 to the olfactory bulb. The migration of thallium-201 to the olfactory bulb is reduced in patients with impaired olfaction due to head trauma, upper respiratory tract infections, and chronic rhinosinusitis, relative to the values in healthy volunteers. Nasally administrating thallium-201 followed by single photon emission computed tomography, X-ray computed tomography and magnetic resonance imaging might be useful in choosing candidates for clinical trials of nasal drug delivery methods to the brain.
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, Kanazawa Medical University, Ishikawa, Japan. shigah@kanazawa-med.ac.jp
authors.forename: Hideaki
authors.initials: H
authors.lastname: Shiga
authors.forename: Junpei
authors.initials: J
authors.lastname: Yamamoto
authors.forename: Takaki
authors.initials: T
authors.lastname: Miwa
mesh_terms: D000818:Animals; D001692:Biological Transport; D001812:Blood-Brain Barrier; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging; D000857:Olfaction Disorders / Q000175:diagnosis* / Q000378:metabolism; D009830:Olfactory Bulb / Q000378:metabolism; D009832:Olfactory Nerve / Q000378:metabolism*; D061219:Olfactory Nerve Injuries / Q000175:diagnosis* / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000378:metabolism; D013794:Thallium Radioisotopes / Q000378:metabolism; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D019275:Radiopharmaceuticals; D013794:Thallium Radioisotopes